This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Developed with Silgan Dispensing’s Bioequivalence (BE) Program, the Gemini™ BE nasal pump is adaptable to match specific formulations for performance fit and quick time-to-market. With an extensive five-stage custom process, Gemini™ allows for customizability with over 40 different spray configurations.
Additional benefits of the Gemini™ BE nasal pump include:
- Cleanroom, pharma-grade, and ISO-certified production
- High-dosing accuracy
- Low strokes to prime
- Capability to match existing reference listed drug (RLD) devices across a range of formulations
- Ability to modify spray characteristics like DSD, plume geometry, and spray pattern
“Bioequivalence testing helps our customers overcome regulatory and technical barriers that have previously slowed product commercialization,” says Allan Houston, vice president sales & marketing, healthcare at Silgan Dispensing. “The Gemini™ BE nasal pump showcases our BE Program and Silgan Dispensing’s ability to deliver expedited nasal devices that fit our customers’ needs as a replacement or secondary supply chain option.”